finance.yahoo.com
Positivefinance.yahoo.com ·
Time Rethink Charles River Laboratories
Policy1RegulationTech AutomationHistoric
Topic context
This topic has been covered 410183 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article discusses Charles River Laboratories' stock valuation and financial projections, but does not describe any concrete commercial mechanism, supply chain event, or regulatory change. The analysis is purely financial (DCF) with no operational or market impact. Therefore, no material sector impact is detected beyond the company's own equity valuation.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Charles River Laboratories stock price ~$181.68, up 8.8% over past week, 7.2% over past month.
- Year-to-date decline of 10.2%, five-year drop of 43.4%.
- DCF analysis estimates intrinsic value ~$140.41, implying 29.4% overvaluation.
- Latest twelve-month FCF ~$368.5 million, projected to rise to $444.99 million by 2035.
